As of May 25
| +0.44 / +3.40%|
The 6 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 28.00 and a low estimate of 10.50. The median estimate represents a +49.59% increase from the last price of 13.37.
The current consensus among 7 polled investment analysts is to Buy stock in Lexicon Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.